Report on assessment of surgical procedures for the treatment of obesity released by EUnetHTA

02

Sep 2021

At the beginning of August 2021, the European Network for Health Technology Assessment, EUnetHTA, released a final report on the surgical procedures for the treatment of obesity. The evaluation was aimed to determine the comparative effectiveness and potential superiority of different bariatric procedures for the treatment of adult obesity in improving outcomes of importance for patients with weight loss, diabetes control, etc.

The following key conclusions are provided:

  • The results suggest little or no difference in the effects of different bariatric surgery procedures on weight loss and diabetes control. However, the results are based mainly on low to very low certainty evidence, with few or even single studies providing data for many of the comparisons;
  • No evidence was found for the effectiveness of the more recent single anastomosis duodenal-ileal bypass with sleeve gastrectomy or single anastomosis sleeve ileal bypass procedures;
  • No study reported on patient satisfaction with the procedure;
  • More high-quality research is needed to determine the relative effect of most obesity surgery procedures, as results for many comparisons are based on data from few studies at high risk of bias;
  • There is a need for studies with longer follow-up in order to assess the long-term effects of obesity surgery;
  • There is a need for standardized definitions, uniform classifications of adverse events, and reporting standards in this field of research to improve the evidence base.

The full details in English can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

21

Sep 2021

In August 2021, the mini-HTA evaluation of the robot-assisted percutaneous coronary intervention was released. The method was described as safe and effective. After the introduction into the clinical practice, the method should be followed up for two years with a sufficient number of procedures to understand the real benefit. All procedures are to be registered in the Norwegian Registry for Invasive Cardiology.

Read more

17

Sep 2021

In mid-August 2021, the Finnish Coordinating Center for Health Technology Assessment announced the release of the four accomplished rapid hospital assessments (HTA) performed by the Helsinki University Hospital. The accomplished rapid HTAs concern the cardiovascular, peripheral vascular, and endoscopy technology groups.

Read more

16

Sep 2021

On August 17, 2021, the National Institute of Public Health released a rapid HTA report on the evaluation of PD-L1 assays in urothelial carcinoma commissioned by the Ordering Forum. This assessment does not provide any conclusions on the effectiveness of various treatment strategies in the treatment of urothelial carcinoma in adults.

Read more

15

Sep 2021

On August 19, 2021, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the MammaPrint and EndoPredict tests for various reasons.

Read more

09

Sep 2021

On August 23, 2021, the Institute for Quality and Efficiency in Health Care (IQWiG) has presented an updated draft version (6.1) of its general methods. The interested parties can submit written comments until the deadline of October 4, 2021.

Read more